X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2015 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
ABBOTT INDIA LIMITED (500488 | ABBOTINDIA~EQ) Detailed Financial Information - ABBOTT INDIA LIMITED Company Fact Sheet and Latest Results - Equitymaster.com
Investing in India? Get Equitymaster Research  

ABBOTT INDIA LIMITED  (KNOL)


 
abbott india - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 5,228.2       No. of shares m 21.25
    Mkt Cap Rs m 111,099       % ch % 2.0
    Vol '000 2.6       % ch week % 9.3
    P/E X 48.5       % ch 1-mth % 11.7
    P/CF X 50.4       % ch 12-mth % 100.8
    EPS (TTM) Rs 107.7       52 week H/L Rs 5,288.0/2,635.0
(As on Sep 4, 2015 (Close)) »  Best Performing pharmaceuticals Stocks

DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Nov-09
13
Dec-10
12
Dec-11
12
Dec-12
15
Mar-14
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs7591,7001,6831,8071,793 
Low Rs3627061,1781,3751,300 
Sales per share (Unadj.) Rs556.3723.6701.3777.71,080.9 
Earnings per share (Unadj.) Rs56.744.556.768.193.4 
Diluted earnings per shareRs36.528.756.768.193.4 
Cash flow per share (Unadj.) Rs63.252.863.777.3103.7 
Dividends per share (Unadj.) Rs17.0017.0017.0017.0023.00 
Adj. dividends per shareRs10.9410.9417.0017.0023.00 
Dividend yield (eoy) %3.01.41.21.11.5 
Book value per share (Unadj.) Rs198.5223.2256.0304.4370.8 
Adj. book value per shareRs127.8143.7256.0304.4370.8 
Shares outstanding (eoy) m13.6813.6821.2521.2521.25 
Bonus/Rights/Conversions  --A-- 
Price / Sales ratio x1.01.72.02.01.4 
Avg P/E ratio x9.927.025.323.416.6 
P/CF ratio (eoy) x8.922.822.520.614.9 
Price / Book Value ratio x2.85.45.65.24.2 
Dividend payout %30.038.230.025.024.6 
Avg Mkt Cap Rs m7,66816,45730,39833,80932,858 
No. of employees `0001.31.82.42.72.8 
Total wages/salary Rs m6241,1121,6732,0622,997 
Avg. sales/employee Rs Th5,818.05,602.26,145.26,196.88,304.0 
Avg. wages/employee Rs Th477.1629.3689.9773.21,083.7 
Avg. net profit/employee Rs Th592.5344.7496.4542.6717.5 
  INCOME DATA
Net Sales Rs m7,6109,89914,90216,52722,969 
Other income Rs m293360197223482 
Total revenues Rs m7,90310,25915,09916,75023,451 
Gross profit Rs m9736941,7552,0182,683 
Depreciation Rs m90113150195219 
Interest Rs m20001 
Profit before tax Rs m1,1749411,8022,0462,946 
Minority Interest Rs m00000 
Prior Period Items Rs m-4-13-4300 
Extraordinary Inc (Exp) Rs m0001040 
Tax Rs m395319555703961 
Profit after tax Rs m7756091,2041,4471,985 
Gross profit margin %12.87.011.812.211.7 
Effective tax rate %33.633.930.834.432.6 
Net profit margin %10.26.28.18.88.6 
  BALANCE SHEET DATA
Current assets Rs m3,3894,0296,8637,73910,029 
Current liabilities Rs m1,1431,4792,3852,2962,940 
Net working cap to sales %29.525.830.032.930.9 
Current ratio x3.02.72.93.43.4 
Inventory Days Days4947625858 
Debtors Days Days2124323117 
Net fixed assets Rs m4915068001,092995 
Share capital Rs m137137212213213 
"Free" reserves Rs m2,5232,8615,1736,2007,610 
Net worth Rs m2,7163,0545,4416,4697,879 
Long term debt Rs m00000 
Total assets Rs m3,8814,5347,9139,07111,392 
Interest coverage x588.0NMNM10,231.03,682.9 
Debt to equity ratio x00000 
Sales to assets ratio x2.02.21.91.82.0 
Return on assets %20.013.415.216.017.4 
Return on equity %28.519.922.122.425.2 
Return on capital %43.230.432.333.237.4 
Exports to sales %0.60.70.40.70.6 
Imports to sales %5.14.47.910.715.9 
Exports (fob) Rs m447459120141 
Imports (cif) Rs m3894311,1761,7643,659 
Fx inflow Rs m86123113179240 
Fx outflow Rs m5476261,5172,1174,041 
Net fx Rs m-461-503-1,404-1,937-3,801 
  CASH FLOW
From Operations Rs m 372 461 241 1,014 1,545 
From Investments Rs m -8 -158 51 -585 -1,431 
From Financial Activity Rs m -234 -272 -420 -420 -424 
Net Cashflow Rs m 130 31 -129 8 -309 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for abbott india limited

 Share Holding
Indian Promoters : 0.0%
Foreign collaborators : 75.0%
Indian inst/Mut Fund : 7.9%
FIIs : 0.1%
ADR/GDR : 0.0%
Free float : 17.1%
Shareholders : 18,270
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 3-4, Corporate Park, Sion Trombay Road, Mumbai - 400 071
    E-MAIL: investor.relations@abbott.co.in     WEB: www.abbott.co.in
    TELEPHONE: (022) 6797 8888     FAX: (022) 6797 8727
    SECTOR: PHARMACEUTICALS     GROUP: M N C
    TR AGENT: Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
    AUDITOR: Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 0.4

More pharmaceuticals Company Fact Sheets:   WYETH LTDUNICHEM LABPIRAMAL ENTERPRISESASTRAZENECA PHARMATORRENT PHARMA

Views on news

Cipla Limited: On a growth drive (Cool Hand Luke)

Mar 21, 2014

Luke Verghese discusses that Cipla's financials are on a roll

GSK pharma's Open offer: Our view (Company Info)

Dec 17, 2013

Should investors take advantage of the buy back offer and offload shares of GSK Pharma?

Foreign investment in pharma; walking a thin line (What We're Reading)

Oct 9, 2013

Here is today's recommended reading list from Equitymaster...

Divi's Laboratories: Cash rich operations (Cool Hand Luke)

Sep 24, 2013

Luke Verghese discusses that Divi's Laboratories is professionally managed

Sun Pharma Advanced Research: Strong R&D focus (Cool Hand Luke)

Sep 18, 2013

The Company is being very judiciously funded through permanent capital, and unsecured debt at favourable terms

More Views on News

Most Popular

Markets are crashing. Here's what you should do(The 5 Minute Wrapup)

Aug 24, 2015

Between good news and good prices, what should long term investors choose?

Calculating Price Targets Based On the Head and Shoulder Pattern(Daily Profit Hunter)

Aug 22, 2015

Apurva Sheth shows to calculate price targets on the head and shoulder pattern

No jobs, no sales: Everything is going wrong with real estate(The Daily Reckoning)

Aug 28, 2015

As fewer new homes are being built, the construction industry is feeling the heat.

Things get worse for steel producers(Chart Of The Day)

Aug 22, 2015

Capacity utilization in the global steel industry nosedives in July.

Buying an under-construction property? Keep this in mind...(Mutual Fund Corner)

Aug 26, 2015

Buying an under-construction property, though cheaper, is riskier than buying one that is complete. PersonalFN discusses what you should keep in mind.

More

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA - ALEMBIC PHARMA COMPARISON

Compare Company With Charts

COMPARE ABBOTT INDIA WITH

MARKET STATS

  1. Go